Tag Archives: NIH

Senator Leahy Urges NIH to Exercise “March-in” Rights on Myriad’s Tests

The Bayh-Dole Act of 1980 grants universities the right to elect to take title in any patent application and patent that was made by their researchers with the support of the Government, e.g., NIH. 35 USC s. 200 et seq. This … Continue reading

Posted in Patent Eligible Subject Matter | Tagged , , , , , , , , , , , , | 2 Comments

Appeals Court Overturns Stem Cell Ban

On April 29th, in Sherley v. Sebelius, the U.S. Court of Appeals for the D.C. Cir., (a copy is available at the end of this post) overturned the injunction imposed by the district court, which had blocked the implementation of … Continue reading

Posted in Stem Cells/Cloning | Tagged , , , , , , , , , , , , , , , , , | Leave a comment

TOP BIOTECH STORIES OF 2009 – DON’T FORGET STEM CELL RESEARCH

The lists of the top pharma/biotech stories for 2009 that I have been seeing online focus mostly on the rise of biosimilars, the spate of mergers and the plurality of Hatch-Waxman litigations that have grabbed the headlines almost daily, along … Continue reading

Posted in Stem Cells/Cloning | Tagged , , , | Leave a comment